Published in Proc Natl Acad Sci U S A on May 22, 2001
Relationship between SPRY and B30.2 protein domains. Evolution of a component of immune defence? Immunology (2005) 1.68
MID1 and MID2 homo- and heterodimerise to tether the rapamycin-sensitive PP2A regulatory subunit, alpha 4, to microtubules: implications for the clinical variability of X-linked Opitz GBBB syndrome and other developmental disorders. BMC Cell Biol (2002) 1.10
Mig12, a novel Opitz syndrome gene product partner, is expressed in the embryonic ventral midline and co-operates with Mid1 to bundle and stabilize microtubules. BMC Cell Biol (2004) 1.08
Alpha4 is a ubiquitin-binding protein that regulates protein serine/threonine phosphatase 2A ubiquitination. Biochemistry (2010) 1.06
Control of mTORC1 signaling by the Opitz syndrome protein MID1. Proc Natl Acad Sci U S A (2011) 1.05
The E3 ubiquitin ligase- and protein phosphatase 2A (PP2A)-binding domains of the Alpha4 protein are both required for Alpha4 to inhibit PP2A degradation. J Biol Chem (2011) 1.02
Active transport of the ubiquitin ligase MID1 along the microtubules is regulated by protein phosphatase 2A. PLoS One (2008) 0.99
Cytokine activation of p38 mitogen-activated protein kinase and apoptosis is opposed by alpha-4 targeting of protein phosphatase 2A for site-specific dephosphorylation of MEK3. Mol Cell Biol (2007) 0.97
The phosphatase subunit tap42 functions independently of target of rapamycin to regulate cell division and survival in Drosophila. Genetics (2005) 0.89
Monoubiquitination promotes calpain cleavage of the protein phosphatase 2A (PP2A) regulatory subunit α4, altering PP2A stability and microtubule-associated protein phosphorylation. J Biol Chem (2012) 0.89
Protein phosphatase 2A (PP2A)-specific ubiquitin ligase MID1 is a sequence-dependent regulator of translation efficiency controlling 3-phosphoinositide-dependent protein kinase-1 (PDPK-1). J Biol Chem (2011) 0.88
PP2A as a master regulator of the cell cycle. Crit Rev Biochem Mol Biol (2016) 0.85
The MID1 E3 ligase catalyzes the polyubiquitination of Alpha4 (α4), a regulatory subunit of protein phosphatase 2A (PP2A): novel insights into MID1-mediated regulation of PP2A. J Biol Chem (2013) 0.84
MID1 catalyzes the ubiquitination of protein phosphatase 2A and mutations within its Bbox1 domain disrupt polyubiquitination of alpha4 but not of PP2Ac. PLoS One (2014) 0.81
Microcystin-LR (MCLR) induces a compensation of PP2A activity mediated by α4 protein in HEK293 cells. Int J Biol Sci (2011) 0.79
X-linked microtubule-associated protein, Mid1, regulates axon development. Proc Natl Acad Sci U S A (2013) 0.78
NMR studies of the C-terminus of alpha4 reveal possible mechanism of its interaction with MID1 and protein phosphatase 2A. PLoS One (2011) 0.78
Identification and functional characterization of novel transcriptional enhancers involved in regulating human GLI3 expression during early development. Dev Growth Differ (2015) 0.76
Midline 1 controls polarization and migration of murine cytotoxic T cells. Immun Inflamm Dis (2015) 0.75
Mid1/Mid2 expression in craniofacial development and a literature review of X-linked opitz syndrome. Mol Genet Genomic Med (2015) 0.75
Quantitative proteomics reveals novel protein interaction partners of PP2A catalytic subunit in pancreatic β-cells. Mol Cell Endocrinol (2016) 0.75
The TOR signalling pathway controls nuclear localization of nutrient-regulated transcription factors. Nature (1999) 9.29
Nutrients, via the Tor proteins, stimulate the association of Tap42 with type 2A phosphatases. Genes Dev (1996) 4.92
Tor proteins and protein phosphatase 2A reciprocally regulate Tap42 in controlling cell growth in yeast. EMBO J (1999) 3.63
The TOR nutrient signalling pathway phosphorylates NPR1 and inhibits turnover of the tryptophan permease. EMBO J (1998) 3.54
Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22. Nat Genet (1997) 3.03
Rapamycin induces the G0 program of transcriptional repression in yeast by interfering with the TOR signaling pathway. Mol Cell Biol (1998) 2.91
Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation. Curr Opin Genet Dev (1999) 2.48
B cell receptor-associated protein alpha4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A. Proc Natl Acad Sci U S A (1997) 2.30
The Opitz syndrome gene product, MID1, associates with microtubules. Proc Natl Acad Sci U S A (1999) 1.44
Mutation of Tyr307 and Leu309 in the protein phosphatase 2A catalytic subunit favors association with the alpha 4 subunit which promotes dephosphorylation of elongation factor-2. Biochemistry (1999) 1.36
The mouse Mid1 gene: implications for the pathogenesis of Opitz syndrome and the evolution of the mammalian pseudoautosomal region. Hum Mol Genet (1998) 1.24
Functional characterization of the Opitz syndrome gene product (midin): evidence for homodimerization and association with microtubules throughout the cell cycle. Hum Mol Genet (1999) 1.22
New mutations in MID1 provide support for loss of function as the cause of X-linked Opitz syndrome. Hum Mol Genet (2000) 1.17
TOR signaling regulates microtubule structure and function. Curr Biol (2000) 1.14
Molecular cloning of a cDNA clone encoding a phosphoprotein component related to the Ig receptor-mediated signal transduction. J Immunol (1995) 1.07
Protein phosphatase type-1 and glycogen bind to a domain in the skeletal muscle regulatory subunit containing conserved hydrophobic sequence motif. Biochemistry (1996) 1.00
Glycogen synthase association with the striated muscle glycogen-targeting subunit of protein phosphatase-1. Synthase activation involves scaffolding regulated by beta-adrenergic signaling. J Biol Chem (2000) 0.97
xnf7 functions in dorsal-ventral patterning of the Xenopus embryo. Dev Biol (1997) 0.89
Mitogen-activated protein kinase and cyclin B/Cdc2 phosphorylate Xenopus nuclear factor 7 (xnf7) in extracts from mature oocytes. Implications for regulation of xnf7 subcellular localization. J Biol Chem (1997) 0.87
Inhibition of the Mr 70,000 S6 kinase pathway by rapamycin results in chromosome malsegregation in yeast and mammalian cells. Chromosoma (1998) 0.86
Yeast GAL4 two-hybrid system. A genetic system to identify proteins that interact with a target protein. Methods Mol Biol (1997) 0.81
The tripartite motif family identifies cell compartments. EMBO J (2001) 9.64
Raf-1 activates MAP kinase-kinase. Nature (1992) 7.05
Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell (1990) 6.12
Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem Biophys Res Commun (1989) 4.63
Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science (1992) 3.64
Mitochondrial cytochrome c: preparation and activity of native and chemically modified cytochromes c. Methods Enzymol (1978) 2.87
B cell receptor-associated protein alpha4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A. Proc Natl Acad Sci U S A (1997) 2.30
Correlation of the kinetics of electron transfer activity of various eukaryotic cytochromes c with binding to mitochondrial cytochrome c oxidase. J Biol Chem (1976) 2.25
Protein phosphatase type 1 in mammalian cell mitosis: chromosomal localization and involvement in mitotic exit. J Cell Biol (1992) 2.16
Java-based remote viewing and processing of nuclear medicine images: toward "the imaging department without walls". J Nucl Med (2000) 2.13
Severe recurrent bacterial infections associated with defective adherence and chemotaxis in two patients with neutrophils deficient in a cell-associated glycoprotein. J Pediatr (1982) 2.03
Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility. J Biol Chem (2000) 2.00
Expression of CPI-17 and myosin phosphatase correlates with Ca(2+) sensitivity of protein kinase C-induced contraction in rabbit smooth muscle. J Physiol (2001) 1.96
Phosphotyrosyl-protein phosphatase. Specific inhibition by Zn. J Biol Chem (1981) 1.95
A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy. Cell (1995) 1.95
Modulation of calcium-activated potassium channels from rat brain by protein kinase A and phosphatase 2A. J Neurosci (1991) 1.90
Evaluation of a national surveillance unit. Arch Dis Child (1999) 1.87
Definition of cytochrome c binding domains by chemical modification. III. Kinetics of reaction of carboxydinitrophenyl cytochromes c with cytochrome c oxidase. J Biol Chem (1978) 1.79
Tyrosine phosphorylation of protein phosphatase 2A in response to growth stimulation and v-src transformation of fibroblasts. J Biol Chem (1994) 1.79
Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C alpha and delta isoforms. J Biol Chem (2001) 1.77
Improving memory and control beliefs through cognitive restructuring and self-generated strategies. J Gerontol (1992) 1.69
Protein phosphatase type-1, not type-2A, modulates actin microfilament integrity and myosin light chain phosphorylation in living nonmuscle cells. J Cell Biol (1990) 1.68
Involvement of protein phosphatases 1 and 2A in the control of M phase-promoting factor activity in starfish. J Cell Biol (1989) 1.66
Definitaion of cytochrome c binding domains by chemical modification. Reaction of carboxydinitrophenyl- and trinitrophenyl-cytochromes c with baker's yeast cytochrome c peroxidase. J Biol Chem (1978) 1.64
Protein phosphatase types 1 and/or 2A regulate nucleocytoplasmic shuttling of glucocorticoid receptors. Mol Endocrinol (1991) 1.59
Protein phosphatases modulate the apparent agonist affinity of the light-regulated ion channel in retinal rods. Neuron (1992) 1.54
Perinatal exposure to HIV in Australia, 1982-1994. Med J Aust (1997) 1.54
Insulin activates the kinase activity of the Raf-1 proto-oncogene by increasing its serine phosphorylation. J Biol Chem (1990) 1.49
Effect of basic fibroblast growth factor on myocardial angiogenesis in dogs with mature collateral vessels. J Am Coll Cardiol (1997) 1.42
Kawasaki disease in Australia, 1993-95. Arch Dis Child (1998) 1.42
Cytosolic protein phosphotyrosine phosphatases from rabbit kidney. Purification of two distinct enzymes that bind to Zn2+-iminodiacetate agarose. J Biol Chem (1984) 1.37
Human liver phosphatase 2A: cDNA and amino acid sequence of two catalytic subunit isotypes. Proc Natl Acad Sci U S A (1988) 1.37
Mutation of Tyr307 and Leu309 in the protein phosphatase 2A catalytic subunit favors association with the alpha 4 subunit which promotes dephosphorylation of elongation factor-2. Biochemistry (1999) 1.36
Cytoskeletal integrity in interphase cells requires protein phosphatase activity. Proc Natl Acad Sci U S A (1992) 1.36
Regulation of NMDA receptors in cultured hippocampal neurons by protein phosphatases 1 and 2A. Nature (1994) 1.34
Activation of myosin light chain phosphatase in intact arterial smooth muscle during nitric oxide-induced relaxation. J Biol Chem (2001) 1.31
Protein phosphatase 1 is targeted to microtubules by the microtubule-associated protein Tau. J Biol Chem (1998) 1.30
Differential localization of myosin and myosin phosphatase subunits in smooth muscle cells and migrating fibroblasts. Mol Biol Cell (1997) 1.30
Elapid neurotoxins. Purification, characterization, and immunochemical studies of -bungarotoxin. Biochemistry (1972) 1.26
A novel phosphoprotein inhibitor of protein type-1 phosphatase holoenzymes. Biochemistry (1999) 1.25
Multiple low spin forms of the cytochrome c ferrihemochrome. EPR spectra of various eukaryotic and prokaryotic cytochromes c. J Biol Chem (1977) 1.25
The sulfatase gene family. Curr Opin Genet Dev (1997) 1.25
Methods to distinguish various types of protein phosphatase activity. Methods Enzymol (1988) 1.24
Water, electrolyte, glucose, and glycine absorption in rat small intestinal transplants. Gastroenterology (1988) 1.24
Functional characterization of the Opitz syndrome gene product (midin): evidence for homodimerization and association with microtubules throughout the cell cycle. Hum Mol Genet (1999) 1.22
MID2, a homologue of the Opitz syndrome gene MID1: similarities in subcellular localization and differences in expression during development. Hum Mol Genet (1999) 1.22
Immunogenetics of the Q and TL regions of the mouse. Crit Rev Immunol (1990) 1.18
Molecular basis for substrate specificity of protein kinases and phosphatases. Int J Biochem (1986) 1.16
Rare childhood diseases: how should we respond? Arch Dis Child (2008) 1.14
Definition of cytochrome c binding domains by chemical modification. I. Reaction with 4-chloro-3,5-dinitrobenzoate and chromatographic separation of singly substituted derivatives. J Biol Chem (1978) 1.13
Preparation of cytochrome c2 from Rhodospirillum rubrum. Anal Biochem (1976) 1.13
Phosphorylase phosphatase catalytic subunit. Evidence that the Mr = 33,000 enzyme fragment is derived from a native protein of Mr = 70,000. J Biol Chem (1985) 1.11
Dual Ser and Thr phosphorylation of CPI-17, an inhibitor of myosin phosphatase, by MYPT-associated kinase. FEBS Lett (2001) 1.11
Tyrosylprotein kinase and phosphatase activities in membrane vesicles from normal and Rous sarcoma virus-transformed rat cells. Proc Natl Acad Sci U S A (1981) 1.11
Membrane protein phosphotyrosine phosphatase in rabbit kidney. Proteolysis activates the enzyme and generates soluble catalytic fragments. Biochem J (1987) 1.10
pp54 microtubule-associated protein-2 kinase requires both tyrosine and serine/threonine phosphorylation for activity. J Biol Chem (1991) 1.08
Embryonic expression of the human MID1 gene and its mutations in Opitz syndrome. J Med Genet (2004) 1.07
Analysis of candidate genes at the IBGC1 locus associated with idiopathic basal ganglia calcification ("Fahr's disease"). J Mol Neurosci (2007) 1.07
Protein phosphotyrosine phosphatase purified from the particulate fraction of human placenta dephosphorylates insulin and growth-factor receptors. Biochem J (1988) 1.06
Health effects of the 1991 Kuwait oil fires: a survey of US army troops. J Occup Environ Med (1999) 1.06
Simplified measurement of monoglycerides, diglycerides, triglycerides, and free fatty acids in biological samples. Clin Chem (1971) 1.05
Hirschsprung's disease: the Australian Paediatric Surveillance Unit's experience. Pediatr Surg Int (2003) 1.03
Protein phosphatase 2A suppresses MAP kinase signalling and ectopic protein expression. Cell Signal (1999) 1.02
Do evolutionary changes in cytochrome c structure reflect functional adaptations? Fed Proc (1976) 1.02
Protein phosphatase type-1 and glycogen bind to a domain in the skeletal muscle regulatory subunit containing conserved hydrophobic sequence motif. Biochemistry (1996) 1.00
Defining the structural determinants and a potential mechanism for inhibition of myosin phosphatase by the protein kinase C-potentiated inhibitor protein of 17 kDa. J Biol Chem (2001) 1.00
Protein phosphatase type-1 and type-2 catalytic subunits both bind inhibitor-2 and monoclonal immunoglobulins. J Biol Chem (1986) 0.99
The anti-tumor activity of anti-CTLA-4 is mediated through its induction of IFN gamma. Cancer Immunol Immunother (2001) 0.98
Glycogen synthase association with the striated muscle glycogen-targeting subunit of protein phosphatase-1. Synthase activation involves scaffolding regulated by beta-adrenergic signaling. J Biol Chem (2000) 0.97
Inhibition of myosin/moesin phosphatase by expression of the phosphoinhibitor protein CPI-17 alters microfilament organization and retards cell spreading. Cell Motil Cytoskeleton (2000) 0.96
Phosphorylase phosphatase regulatory subunit. "Western" blotting with immunoglobulins against inhibitor-2 reveals a protein of Mr = 60,000. J Biol Chem (1985) 0.96
Uterine estrogen receptor in vivo: phosphorylation of nuclear specific forms on serine residues. Mol Endocrinol (1991) 0.96
Subunit structure and activation of inactive phosphorylase phosphatase. Biochemistry (1983) 0.96
Growth arrest induced by transforming growth factor beta 1 is accompanied by protein phosphatase activation in human keratinocytes. J Biol Chem (1991) 0.95
Specificity of protein phosphotyrosine phosphatases. Comparison with mammalian alkaline phosphatase using polypeptide substrates. J Biol Chem (1985) 0.95
Birth prevalence of Prader-Willi syndrome in Australia. Arch Dis Child (2003) 0.95
Shiga toxin-producing Escherichia coli can impair T84 cell structure and function without inducing attaching/effacing lesions. Infect Immun (1999) 0.94
Definition of cytochrome c binding domains by chemical modification. II. Identification and properties of singly substituted carboxydinitrophenyl cytochromes c at lysines 8, 13, 22, 27, 39, 60, 72, 87, and 99. J Biol Chem (1978) 0.93
Universal quantum viscosity in a unitary Fermi gas. Science (2010) 0.93
A conserved domain for glycogen binding in protein phosphatase-1 targeting subunits. FEBS Lett (1998) 0.92
Definition of enzymic interaction domains on cytochrome c. Purification and activity of singly substituted carboxydinitrophenyl-lysine 7, 25, 73, 86, and 99 cytochromes c. J Biol Chem (1980) 0.92
Separate intramolecular pathways for reduction and oxidation of cytochrome c in electron transport chain reactions. Proc Natl Acad Sci U S A (1973) 0.92
Differential regulation of multiple hepatic protein tyrosine phosphatases in alloxan diabetic rats. J Clin Invest (1992) 0.92
Hepatic protein tyrosine phosphatases in the rat. Biochem J (1991) 0.91
Serum antibody response in children with Giardia lamblia infection and identification of an immunodominant 57-kilodalton antigen. Parasite Immunol (1991) 0.90
Hepatic protein phosphotyrosine phosphatase. Dephosphorylation of insulin and epidermal growth factor receptors in normal and alloxan diabetic rats. J Clin Invest (1990) 0.89
Regulation of glucose transport and expression of GLUT3 transporters in human circulating mononuclear cells: studies in cells from insulin-dependent diabetic and nondiabetic individuals. Metabolism (1994) 0.89
Mutations of the serine phosphorylated in the protein phosphatase-1-binding motif in the skeletal muscle glycogen-targeting subunit. Biochem J (2000) 0.89
Insulin-stimulated phosphorylation of the protein phosphatase-1 striated muscle glycogen-targeting subunit and activation of glycogen synthase. J Biol Chem (2000) 0.88
Partial purification and characterization of phosphotyrosyl-protein phosphatase from Ehrlich ascites tumor cells. Biochemistry (1982) 0.88
Intestinal amoebiasis and giardiasis in southern Indian infants and children. Trans R Soc Trop Med Hyg (1991) 0.88
Inactivation of raf-1 by a protein-tyrosine phosphatase stimulated by GTP and reconstituted by Galphai/o subunits. J Biol Chem (1996) 0.87
Identification of protein phosphatase 2A as the primary target for microcystin-LR in rat liver homogenates. FEBS Lett (1994) 0.87
PKCα phosphorylation of RhoGDI2 at Ser31 disrupts interactions with Rac1 and decreases GDI activity. Oncogene (2012) 0.86
Histone H1 dephosphorylation is mediated through a radiation-induced signal transduction pathway dependent on ATM. J Biol Chem (1999) 0.86
Pattern of diaphragmatic activity during forced expiratory vital capacity. J Appl Physiol Respir Environ Exerc Physiol (1981) 0.86
Role of exposure databases in epidemiology. Arch Environ Health (1993) 0.85
Phototherapy for hyperbilirubinaemia in low birthweight infants. Arch Dis Child (1974) 0.85
Health beliefs as predictors of HIV-preventive behavior and ethnic differences in prediction. J Soc Psychol (1996) 0.85
Lymphohematopoietic cancers and butadiene and styrene exposure in synthetic rubber manufacture. Ann N Y Acad Sci (1997) 0.85